• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      Ranbaxy Ends Drug Discovery Pact With Merck

      Posted Atonline.wsj.com

      BANGALORE -- Ranbaxy Laboratories Ltd. has discontinued a drug discovery and clinical development collaboration with Merck & Co. Inc. aimed at developing new anti-bacterial and anti-fungal drugs, a spokesman for the Indian drug maker said Thursday.

      He didn't elaborate.

      In May 2008 Ranbaxy and Merck entered an agreement for the joint development of the drugs and the collaboration was initially for five years.

      Ranbaxy was to receive an undisclosed up-front sum, with the potential to receive payments totaling more than $100 million associated with the achievement of various research, development and regulatory milestones for each target included in the collaboration.

      Ranbaxy was also eligible to receive significant royalties on worldwide net sales of any products commercialized under the agreement.

      Jan 25, 2011


      Share this Article!

    Back to top^